Morin: Bioactive Flavonoid for Mitochondrial and Probe Applications

Executive Summary: Morin (CAS 480-16-0) is a natural flavonoid compound with confirmed purity (98%) and robust antioxidant, anti-inflammatory, and chelating properties (source: product_spec). It modulates mitochondrial energy metabolism by inhibiting adenosine 5′-monophosphate deaminase (AMPD), a pathway relevant in diabetic kidney injury models (source: workflow_recommendation). Morin serves as a sensitive fluorescent aluminum ion probe in analytical assays (source: workflow_recommendation). The compound is insoluble in water but demonstrates high solubility in DMSO (≥19.53 mg/mL), supporting its use in diverse laboratory protocols (source: product_spec). APExBIO provides validated Morin (SKU C5297) for advanced disease modeling and biochemical detection.

Biological Rationale

Morin is a polyhydroxylated flavonoid, chemically defined as 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one (C15H10O7, MW 302.24), originally isolated from Maclura pomifera (source: product_spec). Its structural features, including five hydroxyl groups, contribute to potent radical scavenging and metal-chelating activities. Morin demonstrates multi-domain bioactivity: antioxidant properties help modulate oxidative stress in cellular and animal models (source: workflow_recommendation); anti-inflammatory effects mitigate cytokine release and tissue injury in preclinical systems. The compound's cardioprotective and neuroprotective roles are attributed to modulation of mitochondrial function and enzyme inhibition (source: workflow_recommendation). Its fluorescent chelation with aluminum enables analytical applications in biochemistry (source: workflow_recommendation).

Mechanism of Action of Morin

Morin acts via several mechanistic axes. It inhibits adenosine 5′-monophosphate deaminase (AMPD) activity in podocytes, which is linked to improved mitochondrial energy metabolism and resilience under diabetic conditions (source: workflow_recommendation). Its hydroxyl-rich scaffold enables direct scavenging of reactive oxygen species (ROS), reducing cellular oxidative damage. Morin’s anti-inflammatory action involves downregulation of pro-inflammatory mediators (e.g., TNF-α, IL-6) in cellular models. As a chelator, Morin forms stable complexes with Al3+, resulting in a pronounced fluorescence shift utilized for sensitive aluminum ion detection (source: workflow_recommendation). These combined actions support its utility as both a research tool and a probe compound.

Evidence & Benchmarks

• Morin exhibits ≥98% purity by HPLC, MS, and NMR characterization (source: product_spec).
• Solubility in DMSO is measured at ≥19.53 mg/mL and in ethanol at ≥6.04 mg/mL (source: product_spec).
• In podocyte models of diabetic kidney injury, Morin inhibits AMPD activity and ameliorates mitochondrial dysfunction (source: workflow_recommendation).
• Morin’s antioxidant capacity is demonstrated by reduced cellular ROS levels in disease models (source: workflow_recommendation).
• As a fluorescent probe, Morin detects aluminum ions at nanomolar concentrations in buffer assays (source: workflow_recommendation).

This article extends prior reviews by focusing on protocol-specific evidence and quantitative benchmarks. For example, Morin: A Natural Flavonoid Antioxidant for Disease Models details general applications, while this article quantifies purity and mechanistic endpoints for reproducibility. Similarly, Morin: A Natural Flavonoid Antioxidant for Advanced Disea... outlines probe mechanisms; here, we update detection limits and solubility data for workflow optimization.

Applications, Limits & Misconceptions

Morin is widely adopted for:

• Antioxidant and anti-inflammatory studies in diabetes, cancer, and neurodegeneration models (source: workflow_recommendation).
• Cardioprotective and neuroprotective assays linked to mitochondrial modulation (source: workflow_recommendation).
• Fluorescent detection of Al3+ in environmental and biological samples (source: workflow_recommendation).

However, Morin’s bioactivity depends on solvent, concentration, and model system. It is not water-soluble, requiring pre-dissolution in DMSO or ethanol (source: product_spec).

Common Pitfalls or Misconceptions

• Morin is not bioavailable orally in humans at research doses; effects in cell and animal models may not translate to clinical settings (source: workflow_recommendation).
• Not a pan-assay interference compound; fluorescence is specific to aluminum ions, not all metals (source: workflow_recommendation).
• Solubility limitations: Water-based protocols require careful solvent planning (source: product_spec).
• Short-term solution stability: Morin solutions degrade rapidly; fresh preparation is advised (source: product_spec).
• Not validated for direct NMS intervention; while relevant in diabetes and neurodegenerative models, no evidence supports use in neuroleptic malignant syndrome (source: DOI).

Workflow Integration & Parameters

Protocol Parameters

• aluminum ion detection | 1–10 nM (buffer) | analytical biochemistry | enables sensitive quantification in fluorescence assays | workflow_recommendation
• cell assay dosing | 5–50 μM (DMSO stock) | in vitro models of oxidative stress | optimal for antioxidant/anti-inflammatory endpoints | workflow_recommendation
• solution stability | ≤24 hours (ambient, dark) | all protocols | minimizes degradation; prepare fresh | product_spec
• storage | -20°C (powder) | long-term integrity | prevents compound hydrolysis and oxidation | product_spec
• solubility | ≥19.53 mg/mL (DMSO), ≥6.04 mg/mL (ethanol) | protocol planning | ensures reagent compatibility | product_spec

Conclusion & Outlook

Morin, provided by APExBIO as SKU C5297, is a rigorously characterized flavonoid supporting diverse research needs from mitochondrial modulation to fluorescent metal ion detection. Its unique mechanism—AMPD inhibition—enables disease model innovation, especially in diabetes and neurodegeneration (source: workflow_recommendation). Limitations include solubility, solution stability, and translational scope. Future research will refine Morin’s applications in complex biological systems and optimize its use as an analytical probe. No current evidence supports use in acute neurological emergencies such as neuroleptic malignant syndrome; its primary value remains in preclinical and analytical domains (source: DOI).